Literature DB >> 2395796

Optimization of the therapeutic index by adjustment of the rate of drug administration or use of drug combinations: exploratory studies of diuretics.

J Zhi1, G Levy.   

Abstract

The purpose of this investigation was to explore theoretically certain strategies for optimizing the therapeutic index of drugs and to assess these strategies experimentally with two diuretics. Diuretic agents allow dosing rate flexibilities because the temporal profile of diuretic action can vary considerably as long as the total diuretic effect per day is the same. They can also be used in combination. Experiments were designed to determine if the therapeutic index of furosemide and hydrochlorothiazide can be optimized by administering one or the other at a certain rate or by administering the two drugs together in a certain ratio and at a certain rate. Male Lewis rats received one or the other drug, or combinations of the two, by i.v. infusion at different rates. Several timed urine collections were made under steady-state conditions, with excreted urine replaced volume for volume by i.v. lactated Ringer's solution. The urine flow rates and the urinary excretion rates of the diuretics and of Na+ and K+ were determined. The relationship between the diuretic effect of either of the two drugs given alone and the respective drug excretion rate could be described by the Hill equation. The ratio of urine flow rate to K+ excretion rate exhibited a marked dependence on hydrochlorothiazide excretion rate (highest ratio at high excretion rates), whereas the K+/Na+ excretion rate ratio was constant over a wide range of hydrochlorothiazide excretion rates. There was no significant change of these ratios with changing excretion rate of furosemide.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395796     DOI: 10.1023/a:1015855219695

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.

Authors:  B Sigurd; K H Olesen; A Wennevold
Journal:  Am Heart J       Date:  1975-02       Impact factor: 4.749

2.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

3.  Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors:  J G Wagner
Journal:  J Theor Biol       Date:  1968-08       Impact factor: 2.691

4.  On the mechanism of acute tolerance to furosemide diuresis.

Authors:  P A Sjöström; B G Odlind; B A Beermann; M Hammarlund-Udenaes
Journal:  Scand J Urol Nephrol       Date:  1988

Review 5.  Pharmacodynamic considerations in the use of diuretics.

Authors:  D C Brater
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

6.  Furosemide and hydrochlorothiazide do not have a common mode of action.

Authors:  A Small; E J Cafruny
Journal:  J Pharmacol Exp Ther       Date:  1967-06       Impact factor: 4.030

7.  Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.

Authors:  S Christensen; E Steiness; H Christensen
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

8.  Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.

Authors:  T Li; M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1986-10

9.  Acute tolerance development to the diuretic effect of furosemide in the rat.

Authors:  M Hammarlund; L K Paalzow
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

10.  Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.

Authors:  T Shimizu; T Itoh; M Nakamura
Journal:  J Pharmacol Exp Ther       Date:  1989-08       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.